Description
A platinum-based antineoplastic agent that forms DNA adducts specifically in cancer cells, preventing DNA replication and transcription which induces apoptosis; cytotoxic in colon, ovarian, and lung cancer cell lines (IC50s = 0.5-240, 0.12-19.8, and 2.6-6.1 μM, respectively)
Formal name: (SP-4-2)-[1R,2R-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-platinum
Synonyms: Dacplat|Eloxatin™|Elplat|Lipoxal|NSC 266046|RP 54780
Molecular weight: 397.3
CAS: 61825-94-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Cell Death||Research Area|Cancer|DNA Damage and Repair||Research Area|Epigenetics, Transcription, & Translation|RNA, DNA, & Protein Synthesis